Isolating Commercial Discounts from the Gross-to-net Drug Pricing Bubble

Inmaculada (Inma) Hernandez is a Professor with tenure at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences.  She has authored more than 100 scientific articles, including first-authored papers in JAMA, among other leading journals. Her research has been covered by media worldwide and has been featured by the main media outlets. Hernandez currently holds the National Academy of Medicine Fellowship in Pharmacy.

Hernandez has studied extensively the underuse of anticoagulation in stroke prevention in patients with cardiac arrhythmias. She is the principal investigator of an R01 award from NIH to study the impact of the COVID-19 pandemic on patients with cardiovascular disease. She has done important contributions to the study of pharmaceutical pricing. In 2020-2021, Hernandez led a group of investigators evaluating geographic access to COVID-19 vaccine administration locations. Their analyses informed the Pennsylvania Department of Health distribution of COVID-19 vaccines in medically underserved areas.

Hernandez received her PharmD from the University of Navarra in Spain; and her PhD in Health Services Research and Policy from the University of Pittsburgh. Prior to joining UCSD, she served on the facutly at the University of Pittsburgh. She was recognized on the Forbes 30 under 30 list in 2018 and in 2021 she became the first pharmacist to be recognized with the Academy Health Alice S. Hersh Emerging Leader Award. She is a Fellow of the American College of Cardiology and the American Heart Association.

Contact Danielle Martinez if you would like to attend the seminar via Zoom, or meet with the speaker in person.